Skinflammation

Skinflammation is a translational dermatology company based in Leiden, Netherlands, that specializes in accelerating the development of therapies for inflammatory skin diseases. As a spin-off from the Leiden Academic Centre for Drug Research (LACDR), the company provides a bridge between preclinical research and clinical proof-of-concept. They utilize advanced human skin models and innovative clinical trial methodologies to evaluate drug candidates for conditions such as atopic dermatitis and psoriasis. Skinflammation offers services ranging from biomarker discovery to the execution of early-phase clinical trials, helping partners optimize their dermatological drug pipelines. Their expertise includes the use of non-invasive sampling techniques and specialized imaging to provide deep insights into drug mechanism of action in the skin. The company's platform is designed to reduce the risk and cost of dermatology drug development by providing high-quality translational data early in the process.